Clinical Trial Update: Dose-dependent FODMAP Reintroduction in IBS [NA]

View source ↗

Summary

A completed clinical trial evaluating dose-dependent reintroduction of FODMAPs in irritable bowel syndrome is reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Irritable Bowel Syndrome | NA | Status: COMPLETED